» Articles » PMID: 33850563

Detection of Circulating Tumor Cells: Advances and Critical Concerns

Overview
Journal Oncol Lett
Specialty Oncology
Date 2021 Apr 14
PMID 33850563
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Metastasis is the main cause of cancer-related death and the major challenge in cancer treatment. Cancer cells in circulation are termed circulating tumor cells (CTCs). Primary tumor metastasis is likely due to CTCs released into the bloodstream. These CTCs extravasate and form fatal metastases in different organs. Analyses of CTCs are clarifying the biological understanding of metastatic cancers. These data are also helpful to monitor disease progression and to inform the development of personalized cancer treatment-based liquid biopsy. However, CTCs are a rare cell population with 1-10 CTCs per ml and are difficult to isolate from blood. Numerous approaches to detect CTCs have been developed based on the physical and biological properties of the cells. The present review summarizes the progress made in detecting CTCs.

Citing Articles

Multifaceted Approaches in Epithelial Cell Adhesion Molecule-Mediated Circulating Tumor Cell Isolation.

Szerenyi D, Jarvas G, Guttman A Molecules. 2025; 30(5).

PMID: 40076201 PMC: 11901967. DOI: 10.3390/molecules30050976.


Combination of circulating tumor cells, lncRNAs and DNA methylation for the diagnosis of endometrial carcinoma.

Ding H, Wang J, Zhao X, Xiu S, Cai H, Ma J Oncol Lett. 2024; 28(5):545.

PMID: 39310026 PMC: 11413727. DOI: 10.3892/ol.2024.14678.


Identification of circulating tumor cells captured by the FDA-cleared Parsortix PC1 system from the peripheral blood of metastatic breast cancer patients using immunofluorescence and cytopathological evaluations.

Ciccioli M, Kim K, Khazan N, Khoury J, Cooke M, Miller M J Exp Clin Cancer Res. 2024; 43(1):240.

PMID: 39169412 PMC: 11337573. DOI: 10.1186/s13046-024-03149-x.


Extracellular Vesicles for Childhood Cancer Liquid Biopsy.

Singhto N, Pongphitcha P, Jinawath N, Hongeng S, Chutipongtanate S Cancers (Basel). 2024; 16(9).

PMID: 38730633 PMC: 11083250. DOI: 10.3390/cancers16091681.


Enumeration and Molecular Characterization of Circulating Tumor Cell Using an Epithelial Cell Adhesion Molecule/Vimentin/Epidermal Growth Factor Receptor Joint Capture System in Lung Cancer.

Jiang W, Wu J, Lin X, Chen Z, Lin L, Yang J Clin Med Insights Oncol. 2024; 18:11795549241231568.

PMID: 38525298 PMC: 10960340. DOI: 10.1177/11795549241231568.


References
1.
Tayoun T, Faugeroux V, Oulhen M, Aberlenc A, Pawlikowska P, Farace F . CTC-Derived Models: A Window into the Seeding Capacity of Circulating Tumor Cells (CTCs). Cells. 2019; 8(10). PMC: 6829286. DOI: 10.3390/cells8101145. View

2.
Ding P, Wang Z, Wu Z, Zhu W, Liu L, Sun N . Aptamer-based nanostructured interfaces for the detection and release of circulating tumor cells. J Mater Chem B. 2020; 8(16):3408-3422. DOI: 10.1039/c9tb02457c. View

3.
Pramanik A, Jones S, Gao Y, Sweet C, Vangara A, Begum S . Multifunctional hybrid graphene oxide for circulating tumor cell isolation and analysis. Adv Drug Deliv Rev. 2018; 125:21-35. DOI: 10.1016/j.addr.2018.01.004. View

4.
Lin E, Cao T, Nagrath S, King M . Circulating Tumor Cells: Diagnostic and Therapeutic Applications. Annu Rev Biomed Eng. 2018; 20:329-352. DOI: 10.1146/annurev-bioeng-062117-120947. View

5.
Castro-Giner F, Aceto N . Tracking cancer progression: from circulating tumor cells to metastasis. Genome Med. 2020; 12(1):31. PMC: 7082968. DOI: 10.1186/s13073-020-00728-3. View